Consider the following statements-
1. Researchers in the UK on April 14, 2014 for the first time announced to conduct a test on patient of artificial blood made from human stem cells.
2. The trial was conducted by the team of Professor Marc Turner, medical director at the Scottish National Blood Transfusion Service (SNBTS) at the University of Edinburgh.
3. The trial test would be conducted in 2016.
4. The trial will involve three patients with thalassaemia, a disorder of the RBCs that requires regular transfusions.
5. If successful, the trial could pave the way for manufacturing of blood on an industrial scale.
Select the answer using the codes given below-
View solution